Advising a fund on Series A investment in Synthetic Biotechnology Start-Up

Collyer Law LLC advised a venture capital fund on its investment in the Series A fundraising

round of a synthetic biotechnology start-up that develops livestock disease prevention biotechnology. The start-up offers recombinant custom peptides cultivated using synbio microorganisms as an antibiotic replacement for disease prevention and growth promotion in livestock, providing breeders and farmers with humane, sustainable, highly productive agriculture without the use of antibiotics.